Concentrix (NASDAQ:CNXC) Issues Q3 2025 Earnings Guidance

Concentrix (NASDAQ:CNXC - Get Free Report) updated its third quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 2.800-2.910 for the period, compared to the consensus earnings per share estimate of 2.900. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.4 billion. Concentrix also updated its FY 2025 guidance to 11.530-11.760 EPS.

Concentrix Trading Up 1.8%

CNXC stock traded up $0.96 during mid-day trading on Thursday, reaching $55.13. 1,563,656 shares of the stock traded hands, compared to its average volume of 731,902. Concentrix has a 52-week low of $36.28 and a 52-week high of $77.00. The stock's fifty day moving average is $53.62 and its 200-day moving average is $49.36. The company has a market cap of $3.52 billion, a P/E ratio of 13.82, a P/E/G ratio of 0.70 and a beta of 0.56. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 1.22.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its quarterly earnings results on Thursday, June 26th. The company reported $2.30 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.46). Concentrix had a net margin of 2.81% and a return on equity of 16.73%. As a group, sell-side analysts expect that Concentrix will post 10.11 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Wall Street Zen cut Concentrix from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Robert W. Baird increased their price objective on Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday. Bank of America lifted their target price on Concentrix from $59.00 to $65.00 and gave the company a "neutral" rating in a research note on Monday, June 9th. Finally, Barrington Research reissued an "outperform" rating and issued a $54.00 price target on shares of Concentrix in a research report on Tuesday. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $67.75.

Insider Transactions at Concentrix

In other news, Director Olivier Duha sold 29,444 shares of the firm's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $48.52, for a total transaction of $1,428,622.88. Following the transaction, the director now owns 1,155,862 shares in the company, valued at approximately $56,082,424.24. This trade represents a 2.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Cormac J. Twomey sold 500 shares of Concentrix stock in a transaction on Friday, May 30th. The shares were sold at an average price of $57.06, for a total transaction of $28,530.00. Following the completion of the sale, the executive vice president now directly owns 38,130 shares of the company's stock, valued at approximately $2,175,697.80. The trade was a 1.29% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,944 shares of company stock valued at $1,510,158. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Concentrix

Hedge funds have recently bought and sold shares of the business. Geneos Wealth Management Inc. lifted its position in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after buying an additional 522 shares during the last quarter. Royal Bank of Canada raised its stake in shares of Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock valued at $2,643,000 after acquiring an additional 4,133 shares in the last quarter. Focus Partners Wealth bought a new position in shares of Concentrix in the 1st quarter valued at approximately $781,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock worth $8,152,000 after purchasing an additional 21,746 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock worth $23,552,000 after purchasing an additional 181,546 shares during the period. 90.34% of the stock is owned by institutional investors and hedge funds.

Concentrix Company Profile

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.